AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Johnson & Johnson at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Johnson & Johnson brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 817, MR7. Its session covers biomarker discovery and selection across genitourinary cancers and the part pathology plays in that pathway. The company's medicines span oncology, immunology, neuroscience and cardiovascular disease.

OrganizationAMP 2026 Attendance
Johnson & Johnson
New Brunswick, NJ
BiopharmaPlatinum Partner
Johnson & Johnson Innovative Medicine develops medicines in oncology, immunology, neuroscience, cardiovascular disease, pulmonary hypertension and retina.
Booth
Exhibiting at Booth 817, MR7
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
🏅Platinum Partner
Workshop
Wed, Nov 11
8:00am–8:50am
The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers
Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Johnson & Johnson

Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction